Statin use, hyperlipidaemia, and the risk of breast cancer
2002

Statins and Breast Cancer Risk

Sample size: 1233 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kaye J A, Meier C R, Walker A M, Jick H

Primary Institution: Harvard School of Public Health

Hypothesis

Does statin use increase the risk of breast cancer in women aged 50 to 79 with hyperlipidaemia?

Conclusion

The study found no association between current or past statin use and the risk of breast cancer.

Supporting Evidence

  • Women treated with statins had a relative risk of breast cancer of 1.0 compared to those without hyperlipidaemia.
  • Untreated hyperlipidaemia was associated with a relative risk of 1.6 for breast cancer.
  • The study included 224 cases of breast cancer and 1009 matched controls.

Takeaway

The study looked at whether taking cholesterol-lowering drugs called statins affects the chances of getting breast cancer in older women, and it found that it doesn't.

Methodology

Matched case-control study using the General Practice Research Database.

Potential Biases

Potential for selection or information bias.

Limitations

The study could not analyze reproductive risk factors due to lack of data.

Participant Demographics

Women aged 50 to 79 diagnosed with breast cancer.

Statistical Information

P-Value

0.002

Confidence Interval

0.6–1.6

Statistical Significance

p=0.002

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600267

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication